Medicine & Life Sciences
Neoplasms
100%
Apoptosis
72%
Taiwan
71%
Breast Neoplasms
70%
Solanum nigrum
65%
Drug Therapy
55%
Neoplasm Metastasis
51%
Colorectal Neoplasms
48%
Cellular Apoptosis Susceptibility Protein
47%
Hepatocellular Carcinoma
46%
Cisplatin
42%
Therapeutics
41%
glucose-regulated proteins
39%
Survival
37%
Propensity Score
37%
Adenocarcinoma of Lung
34%
Doxorubicin
32%
Autophagy
31%
Non-Small Cell Lung Carcinoma
30%
Lung Neoplasms
29%
Mouth Neoplasms
29%
Chemoradiotherapy
29%
Cell Death
29%
Extracellular Signal-Regulated MAP Kinases
27%
Epithelial-Mesenchymal Transition
27%
Adenocarcinoma
27%
Cohort Studies
26%
Prostatic Neoplasms
26%
honokiol
25%
Radiotherapy
24%
Myeloid Cells
24%
Reactive Oxygen Species
23%
Fluorouracil
22%
Luteolin
22%
tricetin
22%
Cell Movement
22%
HL-60 Cells
22%
Docetaxel
21%
Avemar
21%
Pancreatic Neoplasms
21%
Protein-Tyrosine Kinases
20%
Chromosome Segregation
20%
gemcitabine
19%
Population
19%
Uterine Cervical Neoplasms
19%
Carcinoma
19%
JNK Mitogen-Activated Protein Kinases
19%
Adjuvant Chemotherapy
19%
Quality of Life
18%
Quercetin
18%
Acute Myeloid Leukemia
17%
Drug Resistance
17%
Catenins
16%
SERPIN-B5
16%
Ovarian Neoplasms
16%
Heterografts
16%
Growth
16%
Caspase 8
16%
Glioblastoma
16%
MAP Kinase Signaling System
15%
Stomach Neoplasms
15%
Recurrence
15%
Caspase 3
15%
Colonic Neoplasms
15%
Neoplastic Stem Cells
15%
Cell Cycle Checkpoints
15%
Confidence Intervals
15%
Mefloquine
14%
Phosphotransferases
14%
Chinese Traditional Medicine
14%
Staining and Labeling
14%
Cell Cycle Resting Phase
14%
Complementary Therapies
14%
Cell Line
14%
Esophageal Squamous Cell Carcinoma
14%
Cell Cycle
14%
Computational Biology
14%
Chronic Pain
14%
Pharmaceutical Preparations
14%
Azacitidine
14%
Thrombomodulin
13%
Liver
13%
Camptothecin
13%
Intensity-Modulated Radiotherapy
13%
Decitabine
13%
Hep G2 Cells
13%
Caspases
13%
Flavonoids
13%
G1 Phase
13%
Cetuximab
13%
Cell Proliferation
13%
Esophageal Neoplasms
13%
Fish Oils
13%
Sorafenib
13%
Bone Neoplasms
13%
Genes
12%
Paris
12%
Yang Deficiency
12%
Leukemia
12%
Genomics
12%